Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Estrogen Use in Protection From Cognitive Decline
Authors not listed
Stanford University · 2003
Abstract
This study is designed to assess the effects of estrogen therapy among postmenopausal women at risk for cognitive decline.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Anonymous. (2003). Estrogen Use in Protection From Cognitive Decline. <em>Stanford University</em>. https://clinicaltrials.gov/study/NCT00097058
Vancouver
Anonymous. Estrogen Use in Protection From Cognitive Decline. Stanford University. 2003.
BibTeX
@misc{anon2003Estrog,
title = {Estrogen Use in Protection From Cognitive Decline},
author = {Anonymous},
journal = {Stanford University},
year = {2003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Free Radical Biology and Medicine 2024
Citation only
Mitochondria-tau association promotes cognitive decline and hippocampal bioenergetic deficits during the aging
Société des Produits Nestlé (SPN) 2016
Open access · US-GOV
Trial of a Nutritional Blend to Prevent Cognitive Decline in Older Adults
US Department of Veterans Affairs 1998
Open access · US-GOV
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Taipei Medical University 2022
Open access · US-GOV
Evaluation of Senior Driving Simulation Training on Executive Function, Cognitive Promotion and EEG in Subjective Cognitive Decline and Mild Cognitive Impairment
PubMed Central 2024
Preprint · CC-BY
In vivo neuron-specific expression of C. elegans reprogramming factor orthologs does not alleviate age-related cognitive decline
Seattle Institute for Biomedical and Clinical Research 2002
Open access · US-GOV